Abstract
BackgroundAntiphospholipid antibodies (aPL) are risk factors for Adverse Pregnancy Outcome (APO). The therapeutic strategy to adopt in aPL patients during pregnancy should in fact consider different clinical and serological risk...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have